London Research & Pharmaceuticals presents the advancement of LRP-661, their oral cannabidiol sulphate drug candidate at the prestigious Epilepsy Therapies & Diagnostics Development (ETDD) XVII conference in Miami 15-04-2024, 19:00

GreenIT and Copenhagen Infrastructure Partners to develop three floating offshore wind farms in Italy with 2 GW capacity 22-03-2023, 16:00

Talisman Casualty Insurance Company Offers a Range of 7-03-2023, 00:22